Envelope surface glycoprotein gp120
|
env
|
Curcumin, a potent and safe anti-inflammatory compound, inhibits HIV-1 gp120-mediated upregulation of the proinflammatory cytokines TNF-alpha and IL-6, and the chemokines IL-8, RANTES, and IP-10 in primary human genital epithelial cells |
PubMed
|
|
env
|
Upregulation of the human proteins CCL2, CX3CL1, IL-1beta, and CXCL10 by HIV-1 gp120 involves CB2 receptor in mesencephalic neuronal/glial culture model |
PubMed
|
|
env
|
HIV-1 gp120 inhibits CpG-A-induced secretion of TNF-alpha, IL-6, and IP-10 proteins in plasmacytoid dendritic cells and PBMCs |
PubMed
|
|
env
|
CXCR4-tropic HIV-1 gp120 augments the expression of RANTES, IP-10, MCP-1, and LTN in peripheral blood mononuclear cells (PBMCs), while CCR5-tropic HIV-1 gp120 also induces an increase in both IP-10 and MCP-1 production |
PubMed
|
|
env
|
HIV-1 gp120 inhibits TLR9-mediated upregulation of CD83 and the secretion of inflammatory cytokines TNF-alpha and IL-6, and chemokine IP10 in plasmacytoid dendritic cells (pDC) |
PubMed
|
Envelope transmembrane glycoprotein gp41
|
env
|
A synthetic peptide corresponding to the immunosuppressive domain (amino acids 574-592) of HIV-1 gp41 downregulates the expression of chemokine (C-X-C motif) ligand 10 (CXCL10) in peptide-treated PBMCs |
PubMed
|
Nef
|
nef
|
Nef from the brain-derived HIV-1 isolate YU-2 remarkably upregulates IP-10 expression, which leads to neural cell death |
PubMed
|
Tat
|
tat
|
HIV-1 Tat upregulates CXCL10 mRNA and protein expression in CRT-MG human astroglioma cells |
PubMed
|
|
tat
|
HIV-1 Tat upregulates IP-10 expression through a MAPK dependent mechanism in astrocytes and also induces IP-10 expression in immature dendritic cells, an effect that may facilitate expansion of HIV-1 infection |
PubMed
|
|
tat
|
HIV-1 and the viral protein Tat modulate the expression of chemokine (C-X-C motif) ligand 10 (CXCL10; IP-10) in immature dendritic cells and monocyte-derived macrophages |
PubMed
|
|
tat
|
The synergistic upregulation of CXCL10 expression by HIV-1 Tat and IFN-gamma is inhibited by mu-opioid receptor (MOR) antagonist beta-funaltrexamine in human astrocytes |
PubMed
|
|
tat
|
HIV-1 Tat inhibits CpG-A-induced secretion of TNF-alpha, IL-6, and IP-10 proteins in plasmacytoid dendritic cells and PBMCs |
PubMed
|
|
tat
|
HIV-1 Tat in combination with IFN-gamma and TNF-alpha increases CXCL10 mRNA and protein in human astrocytes through the activation of the p38, Jnk, and Akt signaling pathways and their downstream transcription factors, NF-kappaB and STAT-1alpha |
PubMed
|
|
tat
|
HIV-1 Tat increases CXCL10 expression in IFN-gamma and TNF-alpha stimulated human astrocytes via NADPH oxidase |
PubMed
|
|
tat
|
HIV-1 Tat increases IP-10 protein production in a time-dependent manner in both HCV-infected and uninfected human Huh7.5.1 cells |
PubMed
|
|
tat
|
JAK/STAT pathway plays a major role in Tat/IFN-gamma-mediated CXCL10 induction in macrophages |
PubMed
|
|
tat
|
Tat and IFN-gamma synergistically induce the expression of CXCL10, which is inhibited by MEK1/2 inhibitor and the p38 mitogen-activated protein kinase (MAPK) inhibitor |
PubMed
|
|
tat
|
HIV-1 Tat can downregulate CXCR3-mediated functions by inhibiting the chemotactic activity of IP-10/CXCL10, an effect mediated by Tat amino acids 25-31 |
PubMed
|
Vpr
|
vpr
|
HIV-1 Vpr upregulates the expression of CXCL10 in human monocyte-derived dendritic cells |
PubMed
|
capsid
|
gag
|
Infection with HIV-1 CA mutant N74D upregulates the expression of CXCL10 in primary human monocyte-derived macrophages |
PubMed
|